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Identification of CD3þCD4CD8 T Cells as
Potential Regulatory Cells in an Experimental Murine
Model of Graft-Versus-Host Skin Disease (GVHD)
Fumi Miyagawa1, Naoko Okiyama1, Vadim Villarroel1 and Stephen I. Katz1
We have developed K14-mOVA transgenic (Tg) mice that express membrane-associated ovalbumin (mOVA)
under the control of a K14 promoter, as well as double Tg mice, by crossing them with OT-I mice that have a TCR
recognizing the OVA peptide. When injected with CD8þ OT-I cells, K14-mOVA Tg mice develop graft-versus-host
disease (GVHD), whereas double Tg mice are protected. This suggests that, in double Tg mice, regulatory
mechanisms may prevent infused OT-I cells from inducing GVHD. We demonstrated that, after adoptive transfer,
TCRabþCD3þCD4CD8NK1.1 double-negative (DN) T cells are increased in the peripheral lymphoid organs
and skin of double Tg mice and exhibit a Va2þVb5þTCR that has the same TCR specificity as OT-I cells. These DN
T cells isolated from tolerant double Tg mice proliferated in response to OVA peptide and produced IFN-g in the
presence of IL-2. These cells could also suppress the proliferation of OT-I cells and were able to specifically kill
activated OT-I cells through Fas/Fas ligand interaction. These findings suggest that DN T cells that accumulate in
double Tg mice have regulatory functions and may have a role in the maintenance of peripheral tolerance in vivo.
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INTRODUCTION
Multiple mechanisms of immune tolerance to self-antigen are
required to prevent autoimmunity. Some self-reactive T cells
are deleted during thymic differentiation (Kappler et al., 1987;
Kisielow et al., 1988; Pircher et al., 1989), but others escape
clonal deletion and go on to populate the periphery
(Bouneaud et al., 2000; Walker and Abbas, 2002). These
self-reactive T cells are controlled by peripheral tolerance
mechanisms (Jones et al., 1990; Rocha and von Boehmer,
1991) acting either directly on the self-reactive T cell
(ignorance, anergy, phenotype skewing, apoptosis) or
indirectly via additional cells (tolerogenic dendritic cells,
regulatory T cells (Tregs)) (Walker and Abbas, 2002). There
is growing evidence that these regulatory cells have important
roles in the maintenance of immune tolerance to self-antigens
and foreign antigens. A variety of Tregs have been described,
including CD4þ (Gonzalez et al., 2001; Sakaguchi et al.,
2008; Shevach, 2011), CD8þ (Jiang and Chess, 2000),
CD4CD8 double-negative (DN) TCRabþ cells (Zhang
et al., 2000; Priatel et al., 2001), gdTCRþ cells (Hayday
and Tigelaar, 2003), and natural killer T cells (Sharif et al.,
2002; Duarte et al., 2004). To date, CD4þCD25þ T cells
are the most extensively studied Tregs that have an important
role in preventing the development of autoimmune diseases
and allograft rejection (Sakaguchi et al., 2008; Shevach,
2011).
A novel subset of antigen (Ag)-specific TCRabþCD3þ
CD4CD8NK1.1 DN regulatory T cell has been identified
(Zhang et al., 2000) and has shown to be able to specifically
suppress the activity of auto-, allo-, or xeno-reactive CD8þ T
cells (Zhang et al., 2000; Chen et al., 2003; Ford et al., 2007),
CD4þ T cells (Chen et al., 2003, 2005; Zhang et al., 2007;
Voelkl et al., 2011), B cells (Hillhouse et al., 2010; Zhang
et al., 2007), or dendritic cells (Gao et al., 2011) in several
animal models and humans. Unlike CD4þCD25þ T cells
that execute their function in an Ag-nonspecific manner
(Sakaguchi et al., 2008; Shevach, 2011), DN Tregs can
downregulate immune responses in an Ag-specific manner
both in vitro and in vivo (Zhang et al., 2000; Ford et al., 2002;
Zhang et al., 2002; Chen et al., 2003). This population of DN
Tregs differs from other Tregs in its surface marker expression,
cytokine profile, and mechanism of suppression, and can
specifically suppress CD8þ and CD4þ T cells that are primed
against the same alloantigen (Zhang et al., 2000; Ford et al.,
2002; Young and Zhang, 2002; Chen et al., 2003).
We developed transgenic (Tg) mice that express ovalbumin
(OVA) under the control of the keratin 14 promoter
(K14-mOVA). After passive transfer of OT-I cells, the CD8þ
T cells transfected with a TCR that recognizes OVA peptide in
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association with major histocompatibility complex class I,
these mice develop graft-versus-host disease (GVHD)–like
disease including skin lesions and weight loss (Shibaki et al.,
2004; Miyagawa et al., 2008). However, double Tg mice that
have both K14-mOVA and OT-I TCR (Va2 and Vb5)
transgenes do not develop GVHD after transfer of OT-I cells,
suggesting that peripheral tolerance may be involved.
In this study, we demonstrate that the number of Va2þ
Vb5þCD3þCD4CD8 DN T cells is significantly increased
in peripheral lymphoid organs, as well as in the skin of double
Tg mice. We further demonstrate that the DN T cells from
the peripheral lymphoid organs of double Tg mice are
able to specifically suppress and kill OT-I cells, CD8þ T cells
carrying the same TCR specificity. Thus, these DN T cells are
able to suppress and kill autoreactive CD8þ T cells in this
model and may participate in the immunologic tolerance
exhibited by the double Tg mice when OT-I cells are
adoptively transferred.
RESULTS
Double Tg mice do not develop GVHD after transfer of OT-I
cells
When injected with OT-I cells, K14-mOVA Tg mice regularly
develop GVHD-like disease, including weight loss and
inflammatory skin lesions with histological changes, whereas
double Tg mice generated by crossing K14-mOVA Tg mice
with OT-I mice do not develop GVHD (Figure 1a–c). When
we transferred green fluorescent protein (GFP)þOT-I cells to
these double Tg mice, GFPþOT-I cells did not proliferate in
the skin-draining lymph nodes (SDLNs) or spleens of double
Tg mice compared with those transferred to K14-mOVA mice
(Figure 1d and e). Although the adoptively transferred GFPþ
OT-I cells migrated to the ear skin of K14-mOVA Tg mice, the
percentages of GFPþOT-I cells in the skin of double Tg mice
were significantly decreased compared with those transferred
to K14-mOVA Tg mice (Figure 1f). Flow cytometric analysis
demonstrated that the adoptively transferred GFPþOT-I cells
did not show an activated phenotype in the SDLNs of double
Tg mice (Okiyama et al., unpublished data). These results
suggest that regulatory mechanisms prevent these OT-I cells
from inducing GVHD in double Tg mice. Even adoptive
transfer of CD44highCD62Llow OT-I cells activated in vitro
with OVA peptides and IL-2 that cannot migrate to LNs did
not cause GVHD in the double Tg mice (Supplementary
Figure S1 online).
CD3þCD4-CD8- cells (DN T cells) expressing Va2þVb5þ
TCR are significantly increased in double Tg mice
When percentages of CD4þ , CD8þ , and DN cells were
compared in SDLNs of C57BL/6, K14-mOVA, and double Tg
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Figure 1. Double transgenic (Tg) mice do not develop graft-versus-host disease (GVHD). (a) Weight-course graph. Five million OT-I cells were adoptively
transferred into K14-mOVA and double Tg mice. The mice were weighed daily for 2 weeks. (b) Clinical photographs and (c) hematoxylin and eosin (H&E)–stained
ear tissues of mice 14 days after transfer of 5 106 OT-I cells. *Po0.05 and **Po0.01. Scale bars¼ 50mm. (d, e) The numbers of GFPþOT-I cells in the (d) SDLNs
(cervical LNs, inguinal LNs, and axillary LNs) and (e) spleens of three mice each at 2, 5, 7, and 14 days after adoptive transfer of 5106 GFPþOT-I cells. (f) The
percentages of infiltrating GFPþOT-I cells in cell suspensions from the ear skin of three mice each at 5 and 14 days after transfer of 5 106 GFPþOT-I cells.
GFP, green fluorescent protein; K14, keratin 14; LN, lymph node; mOVA, membrane-associated ovalbumin; SDLN, skin-draining lymph node; WT, wild type.
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mice, DN cells were found to be significantly increased
in SDLNs of double Tg mice (480%) compared with DN
cells in C57BL/6 and K14-mOVA mice (25%; Figure 2a). The
DN cells from C57BL/6 and K14-mOVA Tg mice are mainly
B cells expressing B220. In contrast, an additional population
of DN cells not expressing B220 was detected in LNs of
double Tg mice (Figure 2b). These DN cells included a large
population expressing CD3 (DN T cells; 20.2%; Figure 2b).
We also identified a population of DN T cells in the spleens of
double Tg mice (data not shown).
DN T cells purified from the LNs and spleens of double Tg
mice exhibited the Va2þVb5þ TCR as is present in OT-I cells
(Figure 2c), but not NK1.1, DX5, or gd TCR (Figure 2d).
Consistent with Zhang et al. (2002), who demonstrated that
Ly-6A (Sca-1) is highly expressed on DN Tregs, we also found
that Ly-6A was highly expressed on DN T cells from double Tg
mice (Figure 2d). Thus, adoptively transferred OT-I cells may
be regulated by the DN T cells in LNs and spleens. Interest-
ingly, we found that the percentage of DN T cells was
significantly increased in the skin of double Tg mice compared
with cell suspensions from skin of K14-mOVA mice after
adoptive transfer of GFPþOT-I cells (Figure 2e). These findings
indicate that migrated OT-I cells may be regulated by DN
T cells localized in the skin.
DN T cells proliferate and produce IFN-c in the presence of OVA
peptide and IL-2
To analyze the capacity of the peripheral DN T cells to
proliferate and produce cytokines after Ag stimulation, they
were purified from double Tg mice. As shown in Figure 3a,
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Figure 2. Increase in double negative (DN) T cells in skin-draining lymph nodes (SDLNs) and skin of double transgenic (Tg) mice. (a) SDLN cells were harvested
from the mice and stained with CD4 and CD8. The numbers in the lower left quadrants indicate the percentages of DN cells in SDLNs. (b) The graphs show
expression of B220 or CD3 in the gated CD4CD8 DN populations. (c) DN T cells were purified from pooled lymph nodes (LNs; inguinal LNs, axillary
LNs, and mesenteric LNs) and spleens of double Tg mice and stained with CD3, Va2, and Vb5. Most of the gated CD3þ cells were Va2þVb5þ . (d) Va2þVb5þ
gated cells stained with various antibodies. The Va2þVb5þ gated cells were stained positively for Ly6A. Thin lines represent isotype controls. (e) Percentages of
infiltrating GFP-Va2þVb5þCD4CD8CD3þ cells in the cell suspensions from ears of three mice each at 5 and 14 days after transfer of 5106 GFPþOT-I
cells. GFP, green fluorescent protein; K14, keratin 14; mOVA, membrane-associated ovalbumin.
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Figure 3. Double negative (DN) T cells from lymph nodes (LNs) and spleen of
double transgenic (Tg) mice respond to the ovalbumin (OVA) peptide.
(a) DN T cells (1 105) were stimulated with antigen-presenting cells
(APCs; 1 105) in the presence or absence of 5mg ml1 OVA peptide. The DN
T cells proliferate when cultured with OVA peptide in the presence of IL-2
alone or IL-2 plus IL-4. (b) Production of IFN-g from OT-I cells and DN T cells
was assessed by ELISA. IFN-g is produced by DN T cells with OVA peptide
only in the presence of IL-2 alone or IL-2 plus IL-4. (a, b) Data are
representative of three independent experiments with triplicates in each
experiment (error bars, SD).
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they did not proliferate in response to OVA peptide without
IL-2. However, strong proliferation was observed in response
to Ag when IL-2 was added at the start of culture. This
response was augmented by the addition of IL-4 to the
cultures. Cytokine production by these cells was also assessed
(Figure 3b and Supplementary Table S1 online), but no
cytokine was detected from culture supernatants of the DN
T cells stimulated by Ag in the absence of IL-2. When IL-2 was
added, the DN T cells produced IFN-g (Figure 3b). IL-2, IL-4,
and IL-10 production was also assessed using DN T cells, as
well as OT-I cells. The latter, when stimulated with IL-2 and
IL-4, produced significant amounts of IL-10, suggesting that
DN T cells may exert their suppressive effects by producing IL-
10 (Supplementary Table S1 online). These results suggest that
DN T cells can respond in an Ag-specific manner but require
an exogenous source of IL-2 to maintain their viability and
their capacity to produce cytokines.
Activated DN T cells do not upregulate cell surface CD8 when
cultured with IL-2
To further characterize the DN T cells, the expression of cell
surface markers was examined. Purified DN T cells from
double Tg mice expressed high levels of CD62L, and they did
not express the acute activation markers CD25 and CD69. The
cells also expressed low amounts of CD44 (Figure 4a),
indicating that they have a naive phenotype. After stimulation
with OVA peptide, the number of DN T cells expanded
over 20-fold during 10 days of culture (data not shown). The
expanded DN T cells expressed CD25, CD69, and CD44, and
exhibited reduced expression of CD62L, indicating their
activated status after specific Ag stimulation (Figure 4b). The
activated DN T cells did not upregulate CD8, and retained
the CD4CD8 double-negative phenotype with partially
downregulated expressions of CD3, Va2, and Vb5 at 10 days
after stimulation (Figure 4b), as well as at 2 and 7 days after
stimulation (data not shown). We also examined OVA-specific
cytotoxicity of the activated DN T cells with a killing assay.
DN T cells could not kill EG7 cells, the EL-4 thymoma cells
transfected to endogenously produce the SIINFEKL peptide of
OVA (Figure 4c). However, CD8þ OT-I cells were able to kill
EG7 cells using the same experimental conditions. These
results indicate that the DN T cells do not become cytotoxic
CD8þ lymphocytes even after stimulation with OVA peptide.
DN T cells are able to suppress proliferation of OT-I cells
It has been demonstrated that DN T cells possess regulatory
function and can suppress immune responses mediated by
CD8þ or CD4þ T cells that are syngeneic to the DN T cells
(Zhang et al., 2000). To determine whether the DN T cells
from our double Tg mice have the ability to regulate syngeneic
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Figure 4. Cultured double negative (DN) T cells with IL-2 are activated and retain the DN phenotype. After 10 days of culture, the DN T cells were harvested and
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CD8þ T cells (OT-I cells), carboxyfluorescein succinimidyl
ester (CFSE)–labeled OT-I cells were stimulated with
OVA peptides and cultured with or without DN T cells that
were isolated from double Tg mice and activated in vitro.
CFSE-labeled OT-I cells were reduced in the wells containing
DN T cells (Figure 5). This reduction of OT-I cells indicated
that the DN T cells may kill OT-I cells. When the number of
DN T cells in the culture wells was increased, suppression of
proliferation of OT-I cells was also observed. These results
suggest that the DN T cells are effective regulators of OT-I
cells. The inability of DN T cells, activated in vitro, to suppress
GVHD (Supplementary Figure S2 online) may be due to their
undergoing apoptosis shortly after adoptive transfer.
DN T cells specifically kill syngeneic CD8þ T cells
To determine whether DN T cells isolated from double Tg
mice could kill OT-I cells, DN T cells and OT-I cells
were used as effector cells and target cells, respectively, in a
calcein-release killing assay to detect a perforin-dependent
cytolytic pathway. However, DN T cells did not kill OT-I cells
(Figure 4c). Next, we performed a JAM test using activated
OT-I cells labeled with [3H]-thymidine as target cells to detect
a Fas-dependent pathway. Retention of [3H]-thymidine by
target OT-I cells was inhibited by effector DN T cells in an
effector/target cell ratio–dependent manner (Figure 6a). The
killing of OT-I cells by DN T cells was blocked by the addition
of Fas/Fc fusion protein before and during the JAM test
(Figure 6b). These results indicate that a Fas/Fas ligand (FasL)
interaction is involved in DN T cell–mediated cytotoxicity of
OT-I cells. We next determined the Ag specificity of DN T
cell–mediated cytotoxicity. On the other hand, when activated
Matahari cells that express a TCR with a different Ag
specificity from DN T cells were used as targets, DN cells
were not cytotoxic (Figure 6c). Consistent with a previous
report (Zhang et al., 2000), our data demonstrate that
DN T cells are able to kill activated CD8þ T cells through a
Fas-dependent pathway, and that sharing of the TCR
specificity by both DN T cells and target cells is required for
cytotoxicity to occur.
DISCUSSION
To understand the mechanisms of autoimmunity and tolerance
against skin-associated self-Ag, we developed transgenic mice
that express membrane-tethered or soluble form of a model
self-Ag, OVA, under the control of a K14 promoter (Miyagawa
Peptide (–) DN x20
DN x10
DN x5
DN x2.5
CFSE
100 101 102 103 104
100 100
0
100
100
100 101 102 103 104
CFSE
Counts
100
0
0 0
0
0
100
DN 0
Figure 5. Regulatory function(s) of double negative (DN) T cells from double
transgenic (Tg) mice. Naive OT-I cells were labeled with carboxyfluorescein
succinimidyl ester (CFSE) and cultured with activated DN T cells, and
proliferative responses in the presence of antigen were assessed by flow
cytometry. Figures show gated CD8þCFSEþ cells. Ratios of DN T cells
to OT-I cells are indicated as DN  20 to 2.5.
30
Fas (–)
Fas (+)
OT-I cells Matahari cells
15
0
–15
rmFas/Fc
%
 C
yt
ot
ox
ici
ty
Peptide (–) Peptide (+)
– + – +
40
60
20
0
–20
40
30
20
%
 C
yt
ot
ox
ici
ty
10
0
–10
33 10
E/T ratio
3.3 133 10 3.3
Peptide (–) Peptide (+)
1
E/T ratio
%
 C
yt
ot
ox
ici
ty
a b c
Figure 6. Double negative (DN) T cells specifically kill activated CD8þ T cells through the Fas/Fas ligand (FasL) pathway. (a) OT-I cells were activated by anti-
CD3 mAb, labeled with [3H]-thymidine, and used as target cells (1.5 104 per well). They were pulsed with the ovalbumin (OVA) peptide or left untreated. DN T
cells were incubated with labeled target cells for 18 hours and exhibited cytotoxicity in a dose-dependent manner. (b) Cytotoxicity is inhibited in the presence of a
Fas/Fc fusion protein at an effector/target cell (E/T) ratio of 20:1. (c) OT-I cells and Matahari cells were stimulated independently with anti-CD3 mAb. DN T cells
were stimulated with the OVA peptide. Activated DN T cells were cytotoxic to OT-I cells but not to H-Y peptide-pulsed Matahari cells. (a–c) Data are
representative of three independent experiments with triplicates in each experiment (error bars, SD).
F Miyagawa et al.
CD3þCD4CD8 Regulatory T Cells in GVHD
2542 Journal of Investigative Dermatology (2013), Volume 133
et al., 2010). Using these mice, we have identified several
factors that induce tolerance or attenuate autoimmune
responses (Miyagawa et al., 2008; Gutermuth et al., 2009;
Miyagawa et al., 2012; Paek et al., 2012). In this study,
we report that TCRabþCD3þCD4CD8DN Tregs that are
present in the LNs, spleens, and skin may be potential
regulatory cells to control the tolerance status in double Tg
mice. We have demonstrated that double Tg mice expressing
the transgenes for both OT-I TCR and K14-mOVA develop
tolerance to the OVA Ag, and that DN T cells, which are
increased in double Tg mice, have Ag-specific regulatory
functions. DN T cells from double Tg mice suppress
the proliferation of CD8þ OT-I cells that have the same
TCR specificity as DN T cells. We also demonstrated that DN
T cells selectively kill activated OT-I cells via a Fas/FasL–
dependent mechanism. In addition, DN T cells may exert their
suppressive effects by producing IL-10. Ideally, the ability of
DN T cells could be functionally assessed by in vivo depletion
from tolerant double Tg mice or by adoptive transfer into
K14-mOVA Tg mice. However, owing to the lack of specific
markers on DN T cells, selective depletion of DN T cells is
currently not possible in vivo without affecting other T-cell
subsets. Similarly, the purification of a sufficient number of
DN T cells from double Tg mice for adoptive transfer is not
possible, because only small numbers of these cells can be
purified. Instead, we transferred DN T cells expanded in vitro
together with OT-I cells into K14-mOVA Tg mice to determine
whether DN T cells suppress GVHD. The results showed
that the activated DN T cells did not suppress GVHD
(Supplementary Figure S2 online), a finding that is not
surprising, as injection of activated cells may not mimic
injection of nonactivated DN T cells. Moreover, it is likely
that most activated DN T cells die after adoptive transfer into
K14-mOVATg mice.
Ag-specific DN Tregs were first identified and characterized
by Zhang et al. (2000). They demonstrated that DN Tregs
have an important role in the induction of tolerance
in transplantation murine models of allogeneic skin (Zhang
et al., 2000; Ford et al., 2002) and of xenogeneic heart (Chen
et al., 2003). Since then, several studies have demonstrated
that DN Tregs exhibit immune suppressive effects in an
Ag-specific manner in multiple disease models both in vitro
and in vivo (Chen et al., 2005; Ford et al., 2007; Zhang et al.,
2007; Hillhouse et al., 2010; Young et al., 2003; McIver et al.,
2008; Dugas et al., 2010). DN Treg cells have been reported
to be present in humans (Fischer et al., 2005), and comprise
1–3% of peripheral T cells in normal mice and humans
(Zhang et al., 2000; Fischer et al., 2005).
DN Tregs can exhibit cytotoxicity through various mechan-
isms depending on the type of target cells. They have been
demonstrated to kill syngeneic CD8þ and CD4þ T cells in an
Ag-specific manner through Fas/FasL interaction (Zhang et al.,
2000; Ford et al., 2002). Other studies have shown that DN
Tregs kill autologous B cells via the perforin/granzyme
pathway (Zhang et al., 2007), whereas they kill alloantigen-
expressing dendritic cells mainly through Fas/FasL interaction
(Gao et al., 2011). Our study also demonstrated that
DN T cells kill syngeneic CD8þOT-I cells through the
Fas/FasL-dependent pathway but not through the perforin/
granzyme pathway.
Although the role of DN Tregs in preventing allo- or xeno-
immune responses is well studied, their role in preventing
T cell–mediated autoimmune disease is not well known. Few
studies have addressed this by using self-Ag Tg murine
models. Priatel et al. (2001) suggested that DN T cells
bearing the alloreactive H-2b 2C TCR in Ag-expressing mice
had regulatory function and could suppress autoreactive
CD8þ T-cell proliferation by using a Fas/FasL-dependent
cytolytic mechanism. Subsequently, Ford et al. (2007)
demonstrated that injection of gp33 peptide prevented the
development of type 1 diabetes in gp33 peptide–specific TCR
Tg (P14) mice with increased DN T cells and decreased
CD8þ T cells. These gp33 peptide–activated DN T cells
suppressed proliferation of syngeneic CD8þ T cells via their
cytotoxicity in an Ag-specific manner. Our K14-mOVA Tg
murine model shows that the proportion of DN T cells is
increased in peripheral lymphoid organs, as well as in the skin
in tolerant double Tg mice. The presence of OT-I cells and
DN T cells in the skin of double Tg mice indicates that some
OT-I cells escape from regulation in the peripheral lymphoid
organs and migrate to the skin, but may be further regulated
by local DN T cells. It is unclear as to which regulatory
mechanism dominates in these tolerant double Tg mice.
The data suggest that DN T cells may provide a novel
therapeutic approach to Ag-specific T cell–mediated autoim-
mune diseases.
MATERIALS AND METHODS
Mice
All mice were obtained from the National Cancer Institute Animal
Production Program (Frederick, MD), housed in a clean facility, and
bred and used in accordance with the institutional guidelines. OT-I
mice were obtained from Dr Judy Kapp (Emory University, Atlanta,
GA). Rag-1-deficient OT-I mice were purchased from Taconic
(Germantown, NY). GFPþOT-I Tg mice were generated by crossing
human ubiquitin C promoter-GFP Tg mice (Jackson, ME) with OT-I
mice. K14-mOVA Tg mice have been described previously (Shibaki
et al., 2004). Double Tg mice were generated by crossing K14-mOVA
Tg mice with OT-I mice.
Adoptive transfer
Five million OT-I cells or GFPþOT-I cells in 200ml of phosphate-
buffered saline were injected intravenously into K14-mOVA mice or
double Tg mice. Weight and health status were monitored daily for
14 consecutive days after injection.
Antibodies and flow cytometry
FITC-conjugated anti-CD3, B220, NK1.1, gdTCR, Va2, phycoery-
thrin-conjugated anti-CD4, CD8, CD3, CD62L, CD25, CD69, CD44,
DX5, Ly6A, Vb5, PerCP5.5-conjugated anti-CD8, allophycocyanin-
conjugated anti-CD8, Alexa700-conjugated anti-Va2, allophycocya-
nin-Cy7-conjugated anti-CD4, and biotin-conjugated anti-Vb5
(BD Bioscience, San Jose, CA) mAbs were used for cell surface
analysis. Allophycocyanin-conjugated streptavidin was used for the
visualization of biotin-conjugated mAb. Stained cells were analyzed
on FACSCalibur and LSR II flow cytometers (BD Bioscience).
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Preparation of OT-I cells and Matahari cells
Single-cell suspensions were prepared from pooled LNs and spleens
of OT-I mice, the GFP/OT-I mice. CD8þ cells were purified by
Mouse CD8 T-cell columns (R&D System, Minneapolis, MN). In
some experiments, single-cell suspensions from LNs of Rag-1-defi-
cient OT-I mice were used as CD8þOT-I cells.
Purification of CD3þCD4CD8 DN T cells
DN T cells were purified from pooled LNs (inguinal LNs, axillary LNs,
and mesenteric LNs) and spleens of 6- to 12-week-old double Tg
mice as follows. The lymphocytes were passed through Mouse T-cell
enrichment columns (R&D Systems) and stained with FITC-conju-
gated anti-CD4, CD8, and B220 mAbs. The cells were then incubated
with anti-FITC MicroBeads (Miltenyi Biotec, Auburn, CA) and purified
by negative selection. The purity of DN T cells was routinely
90–98%.
Stimulation of T cells
Purified DN T cells were cultured at a density of 1 106 cells per well
in a 24-well plate in the presence of 2 106 irradiated (3,000 rad)
and sex-matched splenocytes from C57BL/6 mice pulsed with
5mg ml 1 OVA peptide (SIINFEKL) as antigen-presenting cells,
50 ng ml 1 recombinant mouse IL-2, and 30 ng ml 1 recombinant
mouse IL-4 (Peprotech, Rocky Hill, NJ) in 10% fetal bovine serum,
10 mM MEM nonessential amino acids, 1 mM sodium piruvate, 10 mM
HEPES, and penicillin/streptomycin RPMI-1640 culture medium
(complete RPMI) for various times. Activated cells were then used
for experiments. One million GFPþOT-I cells/well in 24-well plates
were cocultured with 1 106 splenocytes from C57BL/6 mice treated
with 1 ng ml 1 SIINFEKL and 50 mg ml 1 mitomycin C (Sigma-
Aldrich, St Louis, MO) in the presence of 20 ng ml 1 recombinant
mouse IL-2 in complete RPMI for 5 days. The activated GFPþOT-I
cells were used for adoptive transfer experiments.
Collection of skin-infiltrating cells
Ears were minced and digested in RPMI-1640 containing 2 mgml 1
Liberase TL (Roche Diagnostics, Indianapolis, IN) at 4 1C overnight
and were then incubated at 37 1C for 30 minutes in RPMI-1640 contai-
ning 2 mgml 1 Liberase TL and 0.04 mg ml 1 DNase I (Sigma-
Aldrich) under gentle agitation. The suspensions were dissociated by
pipetting and were sequentially passed through 70- and 100-mm filters.
Proliferation assays
DN T cells (1 105) were stimulated with antigen-presenting cells
(1 105) in the presence or absence of 5mg ml 1 OVA peptide in a
96-well flat-bottom plate. [3H]-thymidine was added during the last
16 hours of a 3.5-day culture.
ELISA
DN T cells (1 105) or OT-I cells (1 105) were stimulated
with 5mg ml 1 OVA peptide and antigen-presenting cells (1 105).
Supernatants were removed 48 hours later and assayed using ELISA
kits (R&D Systems).
CFSE labeling
OT-I cells (1 107/ml) were labeled with 2mM CFSE (Molecular
Probes, Eugene, OR) in phosphate-buffered saline for 10 minutes at
37 1C. Cells were then washed and resuspended in complete RPMI.
Suppression assay
DN T cells were cultured for 5 days and harvested. Varying numbers
of DN T cells (DN T cells: CFSE-labeled OT-I cells was 2.5–20:1.)
were mixed with CFSE-labeled OT-I cells. After a 2-day incubation,
all the cells in each well were harvested and analyzed by flow
cytometry. Cultures without DN T cells were used as controls.
Killing assays
A calcein AM release assay was used to determine perforin-depen-
dent cytotoxicity. OT-I cells or DN T cells stimulated for 3–5 days
were used as effector cells. As target cells, OT-I cells were activated
with Concanavalin A and IL-2 for 2 days. A thymoma cell line, EL4,
and OVA-expressing EL4 (EG7) were treated with 500 U ml 1 IFN-g
(Peprotech) for 2 days and used as target cells. Target cells were then
labeled with calcein AM (Molecular Probes) and added to 96-well
round-bottom plates (1.5 104/well) with specific ratios of effector
cells for 3 hours at 37 1C. The supernatants were recovered, and
calcein AM release was measured using a CytoFluor 2,350 plate
reader (Millipore, Billerica, MA). Specific lysis¼ ((experimental
spontaneous)/(maximal spontaneous)) 100. Maximal lysis was
achieved with 0.1% Triton X-100, and spontaneous lysis was
obtained by incubating target cells alone. The JAM test was used to
determine Fas-dependent cytotoxicity of DN T cells. DN T cells
stimulated for 3 days were harvested and seeded into 96-well round-
bottom plates as effector cells. The target cells (OT-I cells and
Matahari cells) were stimulated with plate-bound purified anti-CD3
mAb (10mg ml 1; BD Bioscience), and 10mCi ml 1 of [3H]-thymi-
dine was added during the last 18 hours of a 2-day culture. [3H]-
thymidine–labeled target cells were pulsed with peptides for 1 hour,
and then cocultured with the effector cells at 37 1C for 18 hours. The
cells were harvested and counted in a b-counter. Specific cell lysis
was calculated using the following equation: percentage of specific
killing¼ (S E)/S 100, in which E (experimental) is the c.p.m. of
retained DNA in the presence of effector cells, and S (spontaneous) is
the c.p.m. of retained DNA in the absence of effector cells. In some
experiments, DN T cells were treated with 10mg ml 1 Fas/Fc fusion
protein (R&D Systems) to block FasL on DN T cells. Fas/Fc fusion
protein was added 1 hour before and during the killing assays.
Histological analysis
Tissue samples were fixed in 10% neutral-buffered formalin. Paraffin-
embedded tissues were sectioned and stained with hematoxylin
and eosin staining using standard techniques (American HistoLabs,
Rockville, MD).
Statistical analysis
Data were compared using Student’s t-test. Values of Po0.05 were
referred to as a significant difference.
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